Your Notifications
All done, no notifications
Dr. Chakkapong Chakkabat

Dr. Chakkapong Chakkabat

Radiation Oncologist

, Bangkok, Thailand

17 Years of experience

Speaks: English, Thai

Dr. Chakkapong Chakkabat is currently not consulting online with MediGence
View Telemedicine Doctors

About Dr. Chakkapong Chakkabat

  • Dr. Chakkapong Chakkabat is a renowned Thai radiation oncologist with over 20 years of experience.
  • He currently has affiliations with Bangkok Hospital and MedPark Hospital in Bangkok, Thailand.
  • He completed his Doctor of Medicine from the Faculty of Medicine, Chulalongkorn University in 2002.
  • Served as a Research Fellow at the Department of Radiation Oncology, University of Maryland Medical Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, in Baltimore, Maryland, USA, 2012 - 2013.
  • Member of the Thai Medical Council.
  • Fluent in Thai & English.

Conditions treated by Dr. Chakkapong Chakkabat

  • Lymphoma
  • Colorectal Cancer
  • Lung Cancer
  • Prostate, Kidney, and Bladder Cancer
  • Skin Cancer
  • Bile Duct Cancer
  • Breast Cancer

Area of Interest

  • Radiotherapy & Oncology

Qualification

  • Doctor of Medicine, Faculty of Medicine, Chulalongkorn University (2002).

Work Experiences

  • Served as an assistant professor in the radiation oncology division, the Department of Radiology, and the Faculty of Medicine at Chulalongkorn University.
  • Global Team of Board Certified Surgeons and Medical Specialists
  • Written Second Opinion report delivered within 5 days
  • Option to avail the Video Consultation with the Lead Doctor of the board

Access Our most trusted Medical Second Opinion

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Telemedicine Doctors

CERTIFICATIONS (3)

  • Diploma, Thai Board of Radiation Oncology,2008.
  • Visiting Fellow at Department of Radiation Oncology and Brain Tumor Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, Maryland, USA,2013.
  • Research Fellow at Department of Radiation Oncology, University of Maryland Medical Center, University of Maryland Marlene and Stewart Greene-Baum Cancer Center, Baltimore, Maryland, USA, 2012-2013.

MEMBERSHIPS (1)

  • The Thai Medical Council

RESEARCH PAPERS AND PUBLICATIONS (3)

  • Dr. Chakkapong Chakkabat co-authored the review article "A randomised phase II/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity-modulated radiation therapy (IMRT) in nasopharyngeal carcinoma; preliminary result on acute adverse events" published in Radiation Oncology,2015.
  • Co-authored a study titled, "Advances in mechanisms of resistance to aromatase inhibitors." Expert Review of Anticancer Therapy,2014.
  • Co-authored study titled, "Efficacy of intensity-modulated radiotherapy with concurrent carboplatin in nasopharyngeal carcinoma." Radiology and Oncology, 2015.

Share Your Experience about Dr. Chakkapong Chakkabat

Write Your Review

PROCEDURES

  • Adrenal Cancer Treatment
  • Brachytherapy
  • Cholangiocarcinoma (Bile Duct Cancer)
  • Nasopharyngeal Cancer Treatment
  • Papillary Thyroid Cancer Treatment
  • Penile Cancer Treatment
  • Radiation Therapy
  • Small Intestine Cancer Treatment
  • Vaginal Cancer Treatment
  • Vulvar Cancer Treatment

FREQUENTLY ASKED QUESTIONS

Q: Is Dr. Chakkapong Chakkabat’s teleconsultation on the MediGence platform?

A. Dr. Chakkapong Chakkabat is available to teleconsult on the MediGence platform.

Q: How long is the consultation?

A. The consultation can last up to 15 to 30 minutes. It may go beyond the estimated time, which depends on the patient’s queries and the doctor's medical suggestions.

Q: How soon can the consultation be organised?

A. We have Medical specialists and board-certified doctors on our panel of doctors. The consultation will be organised within 24 to 48 hours or based on the availability of the doctor and the patient.

Q: Is a follow-up consultation included in the consultation price?

A. No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.

Q: How do I share my medical record with the doctor for review?

A. The option to share your medical records is available between the steps of the form provided to you on the website.

Q: Can I book my procedure with the doctor post-consultation?

A. Yes. If you are satisfied with the consultation, then you can go ahead with treatment packages for your diagnosis with the help of our case managers.

Q: Can we get an estimate for the procedure?

A. Yes. The cost estimate will be provided to you by our case manager, including the doctor’s opinion, the cost estimate, and the crucial information about traveling to your medical destination.

Reviewer

Dr. Vishwas Kaushik
Dr. Vishwas Kaushik

MBBS, MD

7 Years of Experience

Dr. Vishwas Kaushik is a qualified medical professional holding an MBBS from the prestigious Belgorod State University, Russia, with a strong foundation in clinical medicine and healthcare practice. His comprehensive medical training has equipped him with a profound understanding of evidence-based clinical practices, patient-centered care, and the evolving landscape of modern medicine. With a keen interest in medical research and scientific communication, he consistently translates complex clinical concepts into clear, accurate, and accessible content for diverse audiences. His work reflects a deep commitment to advancing medical knowledge, delivering impactful healthcare insights, and bridging the gap between clinical expertise and accessible medical communication. View More

Last Reviewed - January 2026

Author

Amit Bansal
Amit Bansal

CEO

18 Years of Experience

Amit Bansal is a serial entrepreneur, Co-Founder, and CEO of MediGence. He has more than 17 years of strong technology experience. Having worked for some of the recognized companies in India, Australia and traveled worldwide to help businesses to grow multi-folded under his leadership and strategic guidance.. View More